Seyedmojtaba Seyedmousavi Selected Research

Fungal Eye Infections

10/2016	Virulence Attributes and Antifungal Susceptibility Profile of Opportunistic Fungi Isolated from Ophthalmic Infections.
4/2016	Infrequent Production of Xanthomegnin by Fungal Strains Recovered from Patients with Ocular Mycoses.
4/2016	Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seyedmojtaba Seyedmousavi Research Topics

Disease

20	Aspergillosis 01/2021 - 10/2011
16	Infections 01/2020 - 02/2013
6	Mycoses (Diseases, Fungus) 01/2021 - 01/2015
5	Body Weight (Weight, Body) 01/2017 - 01/2013
3	Fungal Eye Infections 10/2016 - 04/2016
3	Invasive Pulmonary Aspergillosis 07/2015 - 05/2014
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 04/2019
2	Mucormycosis 01/2021 - 11/2016
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2021
1	Candidemia 01/2021
1	Neoplasms (Cancer) 03/2018
1	Chronic Granulomatous Disease 01/2018
1	Asthma (Bronchial Asthma) 01/2018
1	Wounds and Injuries (Trauma) 04/2017
1	Tinea (Ringworm) 02/2017
1	Invasive Fungal Infections 01/2017
1	Neutropenia 01/2017
1	Fusariosis 11/2016
1	scedosporiosis 11/2016
1	Blindness (Hysterical Blindness) 04/2016
1	Pulmonary Aspergillosis 07/2015
1	Pneumonia (Pneumonitis) 04/2015
1	Breakthrough Infections 03/2015
1	Candidiasis (Moniliasis) 10/2013
1	Cysts 02/2012

Drug/Important Bio-Agent (IBA)

11	AzolesIBA 06/2017 - 01/2013
10	Voriconazole (Vfend)FDA LinkGeneric 06/2017 - 01/2013
5	posaconazole FDA Link 06/2017 - 09/2013
4	Anidulafungin FDA Link 04/2016 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2017 - 02/2013
3	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017 - 04/2016
3	liposomal amphotericin B FDA Link 01/2017 - 04/2013
2	Formaldehyde (Formol)FDA Link 01/2021 - 11/2016
2	ParaffinIBA 01/2021 - 11/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2017
2	Antifungal AgentsIBA 04/2019 - 10/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2016 - 06/2016
2	Virulence Factors (Pathogenicity Factors)IBA 10/2016 - 04/2016
2	Ceftazidime (Fortum)FDA LinkGeneric 01/2016 - 04/2015
2	avibactamIBA 01/2016 - 04/2015
2	isavuconazoleIBA 05/2015 - 01/2015
2	ProdrugsIBA 05/2015 - 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	luliconazoleIBA 02/2019
1	latoconazole (lanoconazole)IBA 02/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2018
1	alkaline proteaseIBA 01/2018
1	Interferon Type IIBA 01/2018
1	CalcineurinIBA 11/2017
1	galactomannanIBA 07/2017
1	olorofimIBA 01/2017
1	ibrexafungerpIBA 01/2017
1	T-2307IBA 01/2017
1	nikkomycinIBA 01/2017
1	VL-2397IBA 01/2017
1	sordarinIBA 01/2017
1	SteroidsIBA 01/2017
1	VT-1161IBA 01/2017
1	VT-1129IBA 01/2017
1	albaconazoleIBA 01/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2016
1	Natamycin (Pimaricin)FDA Link 10/2016
1	Caspofungin (Cancidas)FDA Link 04/2016
1	xanthomegninIBA 04/2016
1	Itraconazole (Sporanox)FDA LinkGeneric 04/2016
1	MycotoxinsIBA 04/2016
1	ceftazidime drug combination avibactamIBA 01/2016
1	Micafungin (FK463)FDA Link 07/2015
1	Flucytosine (Ancobon)FDA Link 07/2015
1	TriazolesIBA 01/2015
1	Interferon-gamma (Interferon, gamma)IBA 07/2014
1	Interleukin-10 (Interleukin 10)IBA 07/2014
1	deoxycholate drug combination amphotericin BIBA 10/2013
1	Codon (Codons)IBA 04/2013

Therapy/Procedure

10	Therapeutics 01/2020 - 02/2012
1	Lasers (Laser) 01/2021
1	Immunotherapy 01/2018
1	Contact Lenses 04/2017